Onset Therapeutics announces corporate name change to Onset Dermatologics

Onset Therapeutics, a PreCision Dermatology company and a leader in the development and commercialization of novel, prescription products for the treatment of skin disorders, today announced that it has changed its corporate name to Onset Dermatologics. The name change has been undertaken to emphasize the Company's focus on dermatology and on delivering advanced topical therapies that patients prefer. Onset Dermatologics will be exhibiting its full line of products at Booth # 2170 at the upcoming American Academy of Dermatology Annual Meeting taking place in New Orleans, LA from February 4^th - 8^th.

"We believe that our new name more accurately reflects the Company's roots in medical dermatology and increased emphasis on developing innovative therapies that address the unmet clinical needs of physicians and patients," said Doug Abel, General Manager of Onset Dermatologics.  "Using the drug delivery expertise we have derived from our proprietary Delevo^® Foam Technology platform, we see enormous potential for bringing new products and formulations to dermatologists that will improve clinical outcomes and patient compliance."

The company's assets were recently acquired by PreCision Dermatology, a fully-integrated specialty pharmaceutical company focused on developing, manufacturing, acquiring and marketing a broad portfolio of innovative dermatology products through multiple sales channels. PreCision Dermatology's strong entrepreneurial management team is led by Jeff Nugent, who brings 20 years of dermatology and skin care experience to his new role.